Skip to main content

Prelude Therapeutics Inc

PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001678660

No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Prelude Therapeutics Inc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
+1 vs. Q3 2025
Shares held
28.5M
+1.31M (+4.8%) vs. Q3 2025
Total value
$82.6M
+$43.5M (+111.1%) vs. Q3 2025
New holders
10
14 more added
Sold out
9
15 more reduced

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PRLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 48 institutions
Q1 2021: 60 institutionsQ2 2021: 57 institutionsQ3 2021: 61 institutionsQ4 2021: 75 institutionsQ1 2022: 68 institutionsQ2 2022: 62 institutionsQ3 2022: 53 institutionsQ4 2022: 60 institutionsQ1 2023: 55 institutionsQ2 2023: 55 institutionsQ3 2023: 60 institutionsQ4 2023: 56 institutionsQ1 2024: 58 institutionsQ2 2024: 61 institutionsQ3 2024: 70 institutionsQ4 2024: 62 institutionsQ1 2025: 59 institutionsQ2 2025: 50 institutionsQ3 2025: 47 institutionsQ4 2025: 48 institutionsQ1 2026: 55 institutionsQ2 2026: 75 institutions
Value heldQ4 2025: $82.6M
Q1 2021: $1.41BQ2 2021: $986.6MQ3 2021: $1.12BQ4 2021: $437.6MQ1 2022: $235.4MQ2 2022: $170.9MQ3 2022: $210.3MQ4 2022: $188.3MQ1 2023: $179.6MQ2 2023: $176.2MQ3 2023: $113.1MQ4 2023: $148.3MQ1 2024: $162.1MQ2 2024: $129.2MQ3 2024: $74.0MQ4 2024: $41.0MQ1 2025: $23.3MQ2 2025: $22.0MQ3 2025: $39.1MQ4 2025: $82.6MQ1 2026: $105.2MQ2 2026: $264.3M
Institutions holding PRLD and their total value by quarter
QuarterHoldersValue
Q2 202675$264.3M
Q1 202655$105.2M
Q4 202548$82.6M
Q3 202547$39.1M
Q2 202550$22.0M
Q1 202559$23.3M
Q4 202462$41.0M
Q3 202470$74.0M
Q2 202461$129.2M
Q1 202458$162.1M
Q4 202356$148.3M
Q3 202360$113.1M
Q2 202355$176.2M
Q1 202355$179.6M
Q4 202260$188.3M
Q3 202253$210.3M
Q2 202262$170.9M
Q1 202268$235.4M
Q4 202175$437.6M
Q3 202161$1.12B
Q2 202157$986.6M
Q1 202160$1.41B

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Prelude Therapeutics Inc; share changes are against Q3 2025.

Institutions holding PRLD in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
OrbiMed Advisors LLC10,909,256$31.6M0.65%00.0%Unchanged
Baker Bros. Advisors LP10,123,824$29.4M0.17%00.0%Unchanged
Vanguard Group Inc1,413,986$4.10M0.00%+421,132+42.4%Added
Kynam Capital Management, LP788,867$2.29M0.15%+788,867New
Two Sigma Investments, LP788,695$2.29M0.00%+636,462+418.1%Added
Price T Rowe Associates Inc755,956$2.19M0.00%−120,382−13.7%Reduced
Acadian Asset Management LLC535,703$1.55M0.00%−4,862−0.9%Reduced
Morgan Stanley334,916$971.3K0.00%+50,713+17.8%Added
Marshall Wace, LLP273,883$794.3K0.00%+273,883New
Geode Capital Management, LLC272,886$791.5K0.00%+55,318+25.4%Added
Renaissance Technologies LLC271,300$786.8K0.00%−272,700−50.1%Reduced
BlackRock, Inc.266,280$772.2K0.00%+1,307+0.5%Added
Two Sigma Advisers, LP237,300$688.2K0.00%+14,600+6.6%Added
TD Asset Management Inc160,652$465.9K0.00%00.0%Unchanged
Millennium Management LLC150,997$437.9K0.00%−996,047−86.8%Reduced
Susquehanna International Group, LLP135,909$394.1K0.00%+135,909New
State Street Corp127,292$369.1K0.00%+29,700+30.4%Added
Sphera Funds Management Ltd.122,752$356.0K0.07%+122,752New
Goldman Sachs Group Inc117,477$340.7K0.00%+38,150+48.1%Added
Jane Street Group, LLC111,040$322.0K0.00%+76,218+218.9%Added
Omers Administration Corp73,000$211.7K0.00%+73,000New
Manufacturers Life Insurance Company, The70,546$200.4K0.00%+1,294+1.9%Added
Point72 Asset Management, L.P.59,168$171.6K0.00%+59,168New
Bridgeway Capital Management, LLC53,500$155.2K0.00%00.0%Unchanged
XTX Topco Ltd50,159$145.5K0.00%+34,581+222.0%Added
Northern Trust Corp50,120$145.3K0.00%+13,699+37.6%Added
Colony Group, LLC50,007$145.0K0.00%+50,007New
Connor, Clark & Lunn Investment Management Ltd.46,090$133.7K0.00%+46,090New
Cerity Partners LLC32,953$95.6K0.00%−1,380−4.0%Reduced
Qube Research & Technologies Ltd21,551$62.5K0.00%+21,551New
Prudential Financial Inc15,520$45.0K0.00%−10,320−39.9%Reduced
HSBC Holdings PLC13,652$39.5K0.00%−95−0.7%Reduced
Bank of America Corp9,808$28.4K0.00%+960+10.8%Added
Barclays PLC8,602$24.9K0.00%−110−1.3%Reduced
FMR LLC6,152$17.8K0.00%−2,947−32.4%Reduced
SBI Securities Co., Ltd.2,741$7.95K0.00%00.0%Unchanged
Caldwell Sutter Capital, Inc.2,000$5.80K0.00%+2,000New
UBS Group AG1,857$5.38K0.00%−2,314−55.5%Reduced
Royal Bank of Canada1,742$5.00K0.00%−5,970−77.4%Reduced
Nisa Investment Advisors, LLC1,634$4.74K0.00%00.0%Unchanged
The PNC Financial Services Group, Inc.1,171$3.40K0.00%00.0%Unchanged
CWM, LLC692$2.00K0.00%−527−43.2%Reduced
Group One Trading, L.P.500$1.45K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA95$2760.00%+43+82.7%Added
JPMorgan Chase & Co62$1800.00%−3,817−98.4%Reduced
Optiver Holding B.V.20$580.00%00.0%Unchanged
Citigroup Inc1$30.00%−5,974−100.0%Reduced
IFP Advisors, Inc1$30.00%−17−94.4%Reduced
Shay Capital LLC0$00.00%−100,000−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−75,161−100.0%Sold out
HRT Financial LP0$00.00%−16,901−100.0%Sold out
AQR Capital Management LLC0$00.00%−10,500−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−6,927−100.0%Sold out
EverSource Wealth Advisors, LLC0$00.00%−89−100.0%Sold out
Essential Partners LLC0$00.00%−17−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−15−100.0%Sold out
Simplex Trading, LLC0$00.00%−153−100.0%Sold out